Šalis: Didžioji Britanija
kalba: anglų
Šaltinis: HMA (Heads of Medicines Agencies)
bismuth subnitrate 0 mg/ml
Pfizer Limited
QG52X
Intramammary suspension
VARIOUS PRODUCTS FOR TEATS AND UDDER
Cattle
2012-07-25
AN: 00369/2013 Revised: August 2013 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Boviseal 2.6 g intramammary suspension for cattle (dairy cows). Austria, Denmark and Germany - TEATSEAL 2.6 g intramammary suspension for cattle (dairy cows). Belgium - UBROXEAL 2.6 g intramammary suspension for cattle (dairy cows) Italy, Luxembourg, Netherlands, Portugal, Spain - EASISEAL 2.6 g intramammary suspension for cattle (dairy cows). France - MAMISEAL 2.6 g intramammary suspension for cattle (dairy cows) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 4g intramammary syringe contains: Active substance: Bismuth subnitrate, heavy 2.6g For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Intramammary suspension Greyish white, smooth, unctuous cream. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (dairy cows). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Prevention of new intramammary infections throughout the dry period. In cows considered likely to be free of sub-clinical mastitis, the product can be used on its own in dry cow management and mastitis control. Selection of cows for treatment with the product should be based on veterinary clinical judgement. Selection criteria may be based on the mastitis and cell count history of individual cows, or recognised tests for the detection of sub- clinical mastitis or bacteriological sampling. AN: 00369/2013 Revised: August 2013 Page 2 of 5 4.3 CONTRAINDICATIONS See section 4.7. Do not use the product alone in c Perskaitykite visą dokumentą